UQ drug QED-203 moves toward first in human trials with Ellison Medical Institute backing

June 24, 2026 Australian Biotech

This is a preview of subscriber content

Subscribe now to continue reading.

UniQuest and the Ellison Medical Institute have signed an exclusive licence that could push a promising University of Queensland treatment for advanced prostate cancer into first-in-human trials as early as 2027. …

Subscribe now to continue reading.

Latest Video

What is it with this organisation's obsession with pharmacy and Europe?
July 13, 2026 - Latest News
Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers
July 13, 2026 - Latest News
Mesoblast reports strong cell therapy revenue as first year as uptake grows
July 13, 2026 - Latest News
Can GLP-1s be more transformative than AI - one person believes they already are
July 14, 2026 - Latest News
The age-old argument for supermarket pharmacies misses the point, and the risks
July 14, 2026 - Latest News

UQ drug QED-203 moves toward first in human trials with Ellison Medical Institute backing

This is a preview of subscriber content

Latest Video

Most Read

What is it with this organisation's obsession with pharmacy and Europe?

Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers

Mesoblast reports strong cell therapy revenue as first year as uptake grows

Can GLP-1s be more transformative than AI - one person believes they already are

The age-old argument for supermarket pharmacies misses the point, and the risks

New Stories

Algorae names Nasdaq pharmaceutical chairman to strengthen board

Starpharma raises $32 Million to advance dendrimer cancer programs

Minister recommits to keeping MS medicines on the PBS while awaiting formal advice

Budget outlook now hangs on disability savings, but what about pharmaceuticals

Australian partnership advances gene therapy for Retinitis Pigmentosa

Patients move to reclaim access agenda ahead of sector negotiations

An opportunity to become a global destination for paediatric oncology trials

Sign In

UQ drug QED-203 moves toward first in human trials with Ellison Medical Institute backing

This is a preview of subscriber content

Latest Video

Most Read

What is it with this organisation's obsession with pharmacy and Europe?

Pharmacy Guild rejects Grattan Institute report, describing community pharmacies as essential health providers

Mesoblast reports strong cell therapy revenue as first year as uptake grows

Can GLP-1s be more transformative than AI - one person believes they already are

The age-old argument for supermarket pharmacies misses the point, and the risks

Follow Us

New Stories

Algorae names Nasdaq pharmaceutical chairman to strengthen board

Starpharma raises $32 Million to advance dendrimer cancer programs

Minister recommits to keeping MS medicines on the PBS while awaiting formal advice

Budget outlook now hangs on disability savings, but what about pharmaceuticals

Australian partnership advances gene therapy for Retinitis Pigmentosa

Patients move to reclaim access agenda ahead of sector negotiations

An opportunity to become a global destination for paediatric oncology trials